The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosis

Read full text
Authors: Delphine Van Laethem, Lars Costers, Augusto Miravalle, Enrique Alvarez, Bennett Myers, Aaron Lee Boster, Hanan Al Halawani, Maarten Dewil, Melissa Cambron, Matthias Grothe, Stijn Denissen, Rebecca Bartz
+4 more Diana Sima, Annemie Ribbens, Dirk Smeets, Guy Nagels
Cited by: 1
References: 62

Abstract

Subjective cognitive performance in multiple sclerosis (MS) correlates weakly with objective performance, but is more strongly associated with depression. We aimed to identify symptoms and brain MRI volumes related to subjective and objective cognitive performance. 205 MS subjects, diagnosed within the last 15 years, completed the SymptoMScreen, patient-reported Expanded Disability Status Scale, Neuro-QoL subjective cognitive and fatigue sub-scores, and Beck Depression Inventory. For the objective cognitive assessment the smartphone-based icompanion Symbol test was used. Volumetric variables were calculated from the 52 available brain MRIs using icobrain. A weak correlation was observed between subjective and objective performance (rho = 0.21, p = 0.002). Subjective performance was negatively associated with pain, dizziness, fatigue and depression, while objective performance was negatively related to walking impairment. Objective performance significantly correlated with thalamic volume, while subjective performance did not correlate with any brain volumes. In other words, subjective and objective cognitive performance are related to different clinical markers: subjective performance is linked to invisible symptoms, while objective performance is linked to more visible measurable clinical markers. Integrating both perspectives in clinical practice may provide a more holistic understanding of cognition in MS, allowing for tailored interventions that enhance patient care and quality of life.

Fields of Study & Subjects

Multiple Sclerosis Research Studies Long-Term Effects of COVID-19 Amyotrophic Lateral Sclerosis Research

Publication details

Journal / source
Scientific Reports
Publisher
Springer Science and Business Media LLC
Volume
16
Issue
1
Publication date
16 May 2026
Language
EN